[
    [
        {
            "time": "",
            "original_text": "【国元医药|公司深度】华熙生物深度报告：多维驱动乘风起，颜值经济正当时",
            "features": {
                "keywords": [
                    "华熙生物",
                    "深度报告",
                    "多维驱动",
                    "颜值经济"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【国元医药|公司深度】华熙生物深度报告：多维驱动乘风起，颜值经济正当时",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "西南证券---医药行业2021年5月投资月报：海外疫情时有反复带来不确定性，重点配置基本面和估值匹配品种【行业研究】",
            "features": {
                "keywords": [
                    "西南证券",
                    "医药行业",
                    "投资月报",
                    "海外疫情",
                    "不确定性",
                    "基本面",
                    "估值匹配"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "西南证券---医药行业2021年5月投资月报：海外疫情时有反复带来不确定性，重点配置基本面和估值匹配品种【行业研究】",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]